Literature DB >> 27918899

The effects of SOST on implant osseointegration in ovariectomy osteoporotic mice.

Rui Shu1, Dongqing Ai2, Ding Bai3, Jinlin Song4, Mengyuan Zhao5, Xianglong Han6.   

Abstract

OBJECTIVE: Osteoporosis is a risk factor for implant fixation failure. The inhibition of sclerostin effectively improves bone formation and bone remodeling. Therefore, this study investigated whether SOST deficiency enhances the osseointegration of implants in a mouse model of osteoporosis induced by ovariectomy (OVX).
DESIGN: Osteoporosis was induced in female C57BL/6 and SOST deficient mice by OVX. Titanium implants were placed in the bilateral distal aspects of the femurs. Implants underwent sandblasting and acid-etching after which the structure, surface roughness and chemical components were investigated using scanning electron microscopy (SEM) and energy spectrum analyses. Undecalcified slices, μ-CT, histology analyses and mechanical tests were used to evaluate the osseointegration of implants. The results were compared using one-way ANOVA between four groups.
RESULTS: Sandblasting and acid-etching increased the roughness of the implants. OVX surgery reduced bone formation around the implants in both WT and SOST-/- mice. However, implant osseointegration was significantly improved in the SOST-/- OVX mice compared to the WT OVX mice.
CONCLUSIONS: Inhibition of the SOST gene improved implant fixation in the OVX osteoporotic mice, which suggests a strategy for enhancing implant osseointegration in clinical patients with osteoporosis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Implant; Osseointegration; Osteoporosis; Sclerostin

Mesh:

Substances:

Year:  2016        PMID: 27918899     DOI: 10.1016/j.archoralbio.2016.11.012

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  6 in total

1.  Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.

Authors:  C Liu; L Wang; R Zhu; H Liu; R Ma; B Chen; L Li; Y Guo; Q Jia; S Shi; D Zhao; F Mo; B Zhao; J Niu; M Fu; A N Orekhov; D Brömme; S Gao; D Zhang
Journal:  Osteoporos Int       Date:  2018-08-27       Impact factor: 4.507

Review 2.  Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry.

Authors:  Chufang Liao; Shanshan Liang; Yining Wang; Ting Zhong; Xiangning Liu
Journal:  J Transl Med       Date:  2022-05-13       Impact factor: 8.440

3.  A preliminary, observational study using whole-blood RNA sequencing reveals differential expression of inflammatory and bone markers post-implantation of percutaneous osseointegrated prostheses.

Authors:  Andrew Miller; Sujee Jeyapalina; Jay Agarwal; Mitchell Mansel; James Peter Beck
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

4.  Normal range of BMD in proximal tibia as a different skeletal site at women.

Authors:  Mustafa Arif Aluclu; Fatih Bati; Ersoy Kekilli
Journal:  North Clin Istanb       Date:  2017-01-25

Review 5.  The role of sclerostin and dickkopf-1 in oral tissues - A review from the perspective of the dental disciplines.

Authors:  Mohammad Samiei; Klara Janjić; Barbara Cvikl; Andreas Moritz; Hermann Agis
Journal:  F1000Res       Date:  2019-01-30

6.  Sost Deficiency does not Alter Bone's Lacunar or Vascular Porosity in Mice.

Authors:  Henry Mosey; Juan A Núñez; Alice Goring; Claire E Clarkin; Katherine A Staines; Peter D Lee; Andrew A Pitsillides; Behzad Javaheri
Journal:  Front Mater       Date:  2017-09-13       Impact factor: 3.515

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.